Literature DB >> 21194393

Make a CHANGE: optimising communication and pain management decisions.

Gerhard Müller-Schwefe1, Wolfgang Jaksch, Bart Morlion, Eija Kalso, Michael Schäfer, Flaminia Coluzzi, Frank Huygen, Magdalena Kocot-Kepska, Ana Cristina Mangas, Cesar Margarit, Karsten Ahlbeck, Philippe Mavrocordatos, Eli Alon, Beverly Collett, Dominic Aldington, Andrew Nicolaou, Joseph Pergolizzi, Giustino Varrassi.   

Abstract

The major objectives of the CHANGE PAIN International Advisory Board are to enhance understanding of chronic pain and to develop strategies for improving pain management. At its second meeting, in November 2009, evidence was presented that around one person in five in Europe and the USA experiences chronic pain, and the delay before referral to a pain specialist is often several years. Moreover, physicians' pharmacological approach to chronic pain is inconsistent, as evidenced by the huge variation in treatment between different European countries. It was agreed that efficient communication between physician and patient is essential for effective pain management, and that efficacy/side-effect balance is a key factor in choosing an analgesic agent. The multifactorial nature of chronic pain produces various physical and psychological symptoms, so the management of chronic pain should be tailored to the individual. Pharmacological therapy must be matched to the causative mechanisms responsible, or it is likely to prove ineffective and risk the development of a 'vicious circle'; doses are increased because of inadequate pain relief, but this increases side-effects so doses are reduced, pain relief is then inadequate, so doses are increased, and so on. Pain management decisions should not therefore be based solely on the severity of pain. Based on the concept of individual treatment targets (ITT), the CHANGE PAIN Scale was adopted - a simple, user-friendly assessment tool to improve communication between physician and patient. The 11-point NRS enables the patient to rate the current pain intensity and to set a realistic individual target level. On the reverse are six key parameters affecting the patient's quality of life; clinicians simply need to agree with patients whether improvement is needed in each one. Regular use can establish the efficacy and tolerability of pain management, and the rate of progress towards individual treatment targets.

Entities:  

Mesh:

Year:  2011        PMID: 21194393     DOI: 10.1185/03007995.2010.545377

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  10 in total

1.  Management of chronic pain among older patients: inside primary care in the US.

Authors:  Ming Tai-Seale; Jane Bolin; Xiaoming Bao; Richard Street
Journal:  Eur J Pain       Date:  2011-07-23       Impact factor: 3.931

2.  Patients' recall of diagnostic and treatment information improves with use of the Pain Explanation and Treatment Diagram in an outpatient chronic pain clinic.

Authors:  Hillel M Finestone; Matthew M Yanni; Catherine J Dalzell
Journal:  Pain Res Manag       Date:  2015-04-01       Impact factor: 3.037

3.  Lasting Prolonged-Release Tapentadol for Moderate/Severe Non-Cancer Musculoskeletal Chronic Pain.

Authors:  Boaz G Samolsky Dekel; Sivia Ghedini; Alberto Gori; Alessio Vasarri; GianFranco Di Nino; Rita M Melotti
Journal:  Pain Ther       Date:  2015-01-06

Review 4.  Tramadol/Paracetamol fixed-dose combination for chronic pain management in family practice: a clinical review.

Authors:  Ignacio Morón Merchante; Joseph V Pergolizzi; Mart van de Laar; Hans-Ulrich Mellinghoff; Srinivas Nalamachu; Joanne O'Brien; Serge Perrot; Robert B Raffa
Journal:  ISRN Family Med       Date:  2013-04-11

5.  Comparison of anterior cingulate vs. insular cortex as targets for real-time fMRI regulation during pain stimulation.

Authors:  Kirsten Emmert; Markus Breimhorst; Thomas Bauermann; Frank Birklein; Dimitri Van De Ville; Sven Haller
Journal:  Front Behav Neurosci       Date:  2014-10-09       Impact factor: 3.558

6.  Ultralow Dose of Naloxone as an Adjuvant to Intrathecal Morphine Infusion Improves Perceived Quality of Sleep but Fails to Alter Persistent Pain: A Randomized, Double-blind, Controlled Study.

Authors:  Linda Block; Christopher Lundborg; Jan Bjersing; Peter Dahm; Elisabeth Hansson; Björn Biber
Journal:  Clin J Pain       Date:  2015-11       Impact factor: 3.442

7.  Change Pain: Ever Evolving-An Update for 2016.

Authors:  Joseph V Pergolizzi; Antonella Paladini; Giustino Varrassi; Robert B Raffa
Journal:  Pain Ther       Date:  2016-10-14

Review 8.  The development of chronic pain: physiological CHANGE necessitates a multidisciplinary approach to treatment.

Authors:  Joseph Pergolizzi; Karsten Ahlbeck; Dominic Aldington; Eli Alon; Flaminia Coluzzi; Albert Dahan; Frank Huygen; Magdalena Kocot-Kępska; Ana Cristina Mangas; Philippe Mavrocordatos; Bart Morlion; Gerhard Müller-Schwefe; Andrew Nicolaou; Concepción Pérez Hernández; Patrick Sichère; Michael Schäfer; Giustino Varrassi
Journal:  Curr Med Res Opin       Date:  2013-07-03       Impact factor: 2.580

Review 9.  Pathophysiologic Approach to Pain Therapy for Complex Pain Entities: A Narrative Review.

Authors:  Martina Rekatsina; Antonella Paladini; Alba Piroli; Panagiotis Zis; Joseph V Pergolizzi; Giustino Varrassi
Journal:  Pain Ther       Date:  2020-01-04

Review 10.  The impact of contextual factors on nursing outcomes and the role of placebo/nocebo effects: a discussion paper.

Authors:  Alvisa Palese; Giacomo Rossettini; Luana Colloca; Marco Testa
Journal:  Pain Rep       Date:  2019-06-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.